Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.
Press releases published on April 28, 2025
Balfour Capital Welcomes Amine El Aissaoui as Investment Advisor
EIN Presswire
·
April 28, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, April 28, 2025 /EINPresswire.com/ -- Balfour Capital Group Expands Investment Advisory Excellence with Appointment of Amine El Aissaoui Balfour Capital Group (BCG), a global leader in …
WOOD COUTURE LAUNCHES INDIAN OCEAN OFFICE, BRINGING GLOBAL FF&E EXCELLENCE TO SEYCHELLES AND MAURITIUS
EIN Presswire
·
April 28, 2025
Following Successful completion of Waldorf Astoria Platte Island, Wood Couture strengthens its global footprint with a new branch in Seychelles. VICTORIA, SEYCHELLES, April 28, 2025 /EINPresswire.com/ -- Wood Couture, the global force redefining bespoke …
IFC EDGE celebrates 10 million square meter milestone for green-certified floorspace in Africa
EIN Presswire
·
April 28, 2025
SOUTH AFRICA, April 28, 2025 /EINPresswire.com/ -- • Energy Savings: More than 382,000 Megawatt hours (MWh) per year, over 200,000 MWh of which were contributed by South Africa • Water Savings: More than 9.4 million cubic meters (m3) per year, 6 …
OROCO FILES SHELF PROSPECTUS
GlobeNewswire
·
April 28, 2025
Vancouver, Canada, April 28, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”). is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the “Prospectus“) …
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …
ANWULI JOY FEMI-WALSH HONOURED WITH PRESTIGIOUS FELLOWSHIP AWARD BY THE CENTRE FOR PROCUREMENT EXCELLENCE
EIN Presswire
·
April 28, 2025
Douglas Development Institute Recognises 20 Years of Impact in Public Procurement and International Trade DOUGLAS, DOUGLAS, ISLE OF MAN, April 28, 2025 /EINPresswire.com/ -- ANWULI JOY FEMI-WALSH HONOURED WITH PRESTIGIOUS FELLOWSHIP AWARD BY THE CENTRE …
EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Partnership and First-Ever 5K Sponsorship
EIN Presswire
·
April 28, 2025
From strategic partnership to global employee action, EBC joins the global movement to end malaria for good. DC, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- As the world marks World Malaria Day 2025 under the theme “Malaria Ends With Us: …
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils …
Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté
GlobeNewswire
·
April 28, 2025
NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 28 avr. 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) a le …
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …
XS.com conquista prêmio de “Melhores Ferramentas de IA” no Money Expo Abu Dhabi 2025
EIN Presswire
·
April 28, 2025
BRAZIL, April 28, 2025 /Business News/ -- A XS.com, líder global em FinTech e serviços financeiros, tem o orgulho de anunciar que foi reconhecida com o prêmio de “Melhores Ferramentas de IA” durante sua destacada participação como Patrocinadora Titânio …
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION
GlobeNewswire
·
April 28, 2025
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION Milan, 28th April 2025 – The Board of …
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
Ten (10) patients have achieved an objective response (5 confirmed) when treated with MDNA11 alone or in combination with KEYTRUDA® (pembrolizumab) – all responders had advanced and/or metastatic cancers with resistance to immune checkpoint inhibitors (ICI …
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the signing of an agreement with the Mosakahiken Cree Nation (“MCN”) on exploration activities in their traditional and ancestral …
Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug
GlobeNewswire
·
April 28, 2025
SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent …
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
GlobeNewswire
·
April 28, 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that President and CEO Niven R. Narain, Ph.D. has been named to The Medicine Maker’s Power List 2025. The annual list …
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
GlobeNewswire
·
April 28, 2025
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first …